Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury

AMPK NLRP3 autophagy hydroxysafflor yellow A myocardial ischemia reperfusion injury

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 23 02 2021
accepted: 07 04 2021
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 11 5 2021
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fphar.2020.01170.].

Identifiants

pubmed: 33967813
doi: 10.3389/fphar.2021.671318
pii: 671318
pmc: PMC8100669
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

671318

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2021 Ye, Lu, Wang, Ge, Liu, Qi, Fu, Zhang, Zhang, Sun and Sun.

Auteurs

Jingxue Ye (J)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Shan Lu (S)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Min Wang (M)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Wenxiu Ge (W)

College of Pharmacy, Harbin University of Commerce, Harbin, China.

Haitao Liu (H)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Yaodong Qi (Y)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Jianhua Fu (J)

Pneumology Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Qiong Zhang (Q)

Pneumology Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Bengang Zhang (B)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Guibo Sun (G)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Xiaobo Sun (X)

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Classifications MeSH